Investigating monocyte dysfunction in Down Syndrome
Investigating monocyte dysfunction in Down Syndrome
批准号:
10854106
负责人:
Betsy J Barnes
金额:
$38.37万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-24 至 2024-06-30
关键词:
AcuteAdministrative SupplementAdultArthritisAutoimmune DiseasesB-LymphocytesBasic ScienceCD14 geneCellsCellular Indexing of Transcriptomes and Epitopes by SequencingChildChildhoodChronic Childhood ArthritisCollaborationsComplicationDataData SetDiseaseDown SyndromeFCGR3B geneFreezingFunctional disorderFundingFutureGoalsHashimoto DiseaseImmuneImmune System DiseasesImmune responseImmunityIncidenceIndividualInflammatoryInflammatory ArthritisInflammatory ResponseInnate Immune ResponseInnate Immune SystemInsulin-Dependent Diabetes MellitusInterferonsInterleukin-6KnowledgeLeadLearningLeukocytesLightLongevityMacrophageMacrophage ActivationMacrophage activation syndromeMediatingMedical centerNational Institute of Arthritis, and Musculoskeletal, and Skin DiseasesParentsParticipantPathogenesisPathogenicityPathologyPatientsPeripheral Blood Mononuclear CellPhenotypePhosphorylationPhysiciansPopulationReceptor SignalingRegistriesResearch InstituteRheumatismRheumatoid ArthritisRoleSTAT1 geneSamplingSeveritiesSystemSystemic Lupus ErythematosusT-LymphocyteTissuesToll-like receptorsVirginiaVirus DiseasesWorkadaptive immune responsebiobankcytokinedata sharingexperimental studyhigh rewardhigh riskhuman modelinsightmonocytemouse modelparent grantprogramsresponsesingle-cell RNA sequencingsystemic juvenile idiopathic arthritisvaccine response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
We are requesting an Administrative Supplement for the INCLUDE Project for R01 AR076242 “IRF5 and
Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis”. The proposed studies for the in this
Supplement are within the scope of the active parent grant, focused on Down syndrome (DS) and are aligned
with the goals of the overall INCLUDE Project—Component 1: Targeted high risk – high reward basic science
studies highly relevant to DS. Our studies take advantage of a growing registry and biorepository of DS
individuals that has been established at the Benaroya Research Institute by Drs. Bernard Khor and Jane
Buckner. The objectives of this administrative supplement are to better understand innate immune alterations in
DS. Individuals with DS have immune dysfunction evidenced by decreased vaccine responses, increased
severity of viral infections and increased incidence of certain autoimmune diseases, including autoimmune
thyroiditis, type 1 diabetes and juvenile idiopathic arthritis (JIA). DS individuals also have increased type 1 IFN
responses and increased amounts of some inflammatory cytokines and specific alterations in T and B cells.
However, how these alterations lead to the overall changes in immunity in DS is not well-understood. Importantly,
there has been much focus on adaptive immune responses in DS, with less focus on cells of the innate immune
system, including monocytes and macrophages, important in the pathogenesis of many autoimmune diseases,
including (JIA).
This supplement is within the scope of the Parent R01 as it: 1) investigates monocytes and TLR
responses in these cells, which are the focus of the parent R01, 2) relates to a form of juvenile arthritis seen
more frequently in individuals with DS, as the parent grant focuses on another form of juvenile arthritis (systemic
juvenile idiopathic arthritis (SJIA)), and 3) will leverage our existing single cell RNA-Seq (scRNA-Seq) data
funded by the parent R01. Data generated from this supplement will inform our parent R01 by giving us additional
monocyte scRNA-Seq datasets to compare with our already generated scRNA-Seq datasets from children with
SJIA-associated MAS and matched controls. This supplement is within NIAMS INCLUDE Program priorities to
better understand arthritic disorders in DS across the lifepan. Because monocytes and macrophages are key
players in pathogenesis of all forms of arthritis, understanding whether these cells and their responses are
dysregulated in DS will lead to a better understanding of their contributions to the increased incidence of arthritis
in children with DS.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fimmu.2022.951254
发表时间:
2022
期刊:
FRONTIERS IN IMMUNOLOGY
影响因子:
7.3
作者:
[Matta, Bharati, Battaglia, Jenna, Barnes, Betsy J.]
通讯作者:
Barnes, Betsy J.
DOI:
10.1002/art.41677
发表时间:
2021-08
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
[Lu A, Wu S, Niu J, Cui M, Chen M, Clapp WL, Barnes BJ, Meng G]
通讯作者:
Meng G
Implications for Speckled proteins 110 and 140 in adaptive immunity
-
批准号:10726020
-
项目类别:
-
资助金额:$16.75万
-
财政年份:2023
-
负责人:Betsy J Barnes
-
依托单位:
New role(s) for IRF5 as a regulator of tau accumulation in Alzheimer’s disease
-
批准号:10302599
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2021
-
负责人:Betsy J Barnes
-
依托单位:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
-
批准号:10199939
-
项目类别:
-
资助金额:$57.14万
-
财政年份:2019
-
负责人:Betsy J Barnes
-
依托单位:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
-
批准号:10454915
-
项目类别:
-
资助金额:$57.76万
-
财政年份:2019
-
负责人:Betsy J Barnes
-
依托单位:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
-
批准号:10663266
-
项目类别:
-
资助金额:$57.71万
-
财政年份:2019
-
负责人:Betsy J Barnes
-
依托单位:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
-
批准号:9982787
-
项目类别:
-
资助金额:$58.98万
-
财政年份:2019
-
负责人:Betsy J Barnes
-
依托单位:
Determining the function of IRF5 tumor suppressor in HCV pathogenesis
-
批准号:9108325
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2015
-
负责人:Betsy J Barnes
-
依托单位:
Determining the function of IRF5 tumor suppressor in HCV pathogenesis
-
批准号:9147052
-
项目类别:
-
资助金额:$21.99万
-
财政年份:2015
-
负责人:Betsy J Barnes
-
依托单位:
IRF5-TNPO3 locus: Inclusion of TNPO3 as a unique regulator of IRF5 expression an
-
批准号:8664081
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2014
-
负责人:Betsy J Barnes
-
依托单位:
IRF5-TNPO3 locus: Inclusion of TNPO3 as a unique regulator of IRF5 expression an
-
批准号:9220283
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2014
-
负责人:Betsy J Barnes
-
依托单位:
ROLE OF IRF5 IN SLE PATHOGENESIS
-
批准号:7139435
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2006
-
负责人:Betsy J Barnes
-
依托单位:
ROLE OF IRF5 IN SLE PATHOGENESIS
-
批准号:7455049
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2006
-
负责人:Betsy J Barnes
-
依托单位:
ROLE OF IRF5 IN SLE PATHOGENESIS
-
批准号:7286028
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2006
-
负责人:Betsy J Barnes
-
依托单位:
海外基金